Table 4:
Proportional hazards model for post-recurrence survival based on time since most recent previous surveillance.
| HR (95% CI) | p-value | |
|---|---|---|
| Time since last surveillance (per month) | 1.02 (0.99, 1.04) | 0.432 |
| ≥ 14 months since last surveillance | 1.01 (0.62, 1.65) | |
| Recurrence: Distant | (reference) | 0.020 |
| Local | 0.78 (0.64, 0.96) | |
| Detection: Asymptomatic | < 0.001 | |
| Symptomatic | 1.49 (1.20, 1.85) | |
| Age (per decade) | 1.17 (1.08, 1.27) | < 0.001 |
| Sex: Male | 0.001 | |
| Female | 0.76 (0.64, 0.89) | |
| Histology: Adenocarcinoma | 0.023 | |
| Squamous | 1.29 (1.05, 1.60) | |
| Other histology | 1.20 (0.96, 1.49) | |
| Surgery: Lobectomy | 0.837 | |
| Pneumonectomy | 0.85 (0.58, 1.23) | |
| Segmentectomy | 1.01 (0.66, 1.55) | |
| Wedge resection | 1.04 (0.80, 1.35) | |
| Chronic obstructive pulmonary disease | 1.04 (0.85, 1.28) | 0.684 |
| Congestive heart failure | 1.47 (1.13, 1.92) | 0.004 |
| Coronary artery disease | 0.80 (0.64, 0.98) | 0.034 |
| Diabetes | 1.17 (0.91, 1.51) | 0.229 |
| Peripheral vascular disease | 1.49 (1.16, 1.91) | 0.002 |
| Psychiatric | 0.99 (0.74, 1.33) | 0.963 |
| Substance abuse | 1.36 (0.96, 1.94) | 0.083 |